19. Juli 2024 – Swissmedic launches the public consultation on Guideline M14 titled "Bioequivalence for Immediate-Release Solid Oral Dosage Forms General principles on plan, design, and analysis of pharmacoepidemiological studies that utilize real-world data for safety assessment of medicines". This guideline is part of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH Guidelines). The deadline for submitting comments is on 30 August 2024.

For more information, see here.